Brainport
≈ 3 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
BrainPort is a technology whereby sensory information can be sent to one's brain through an electrode array which sits atop the tongue. It was initially developed by Paul Bach-y-Rita as an aid to people's sense of balance, particularly of stroke victims. Bach-y-Rita founded Wicab in 19981. It has also been developed for use as a visual aid, demonstrating its ability to allow a blind person to see his or her surroundings in polygonal and pixel form. In this scenario, a camera picks up the image of the surrounding, the information is processed by a chip which converts it into impulses which are sent through an electrode array, via the tongue, to the person's brain. The human brain is able to interpret these impulses as visual signals and they are then redirected to the visual cortex, allowing the person to "see." This is similar in part to how a cochlear implant works, in that it transmits electrical stimuli to a receiving device in the body. The BrainPort V100 oral electronic vision aid was approved by the Food and Drug Administration (FDA) on 18 June 2015.
BrainPort is a technology whereby sensory information can be sent to one's brain through an electrode array which sits atop the tongue. It was initially developed by Paul Bach-y-Rita as an aid to people's sense of balance, particularly of stroke victims. Bach-y-Rita founded Wicab in 1998. It has also been developed for use as a visual aid, demonstrating its ability to allow a blind person to see his or her surroundings in polygonal and pixel form. In this scenario, a camera picks up the image of the surrounding, the information is processed by a chip which converts it into impulses which are sent through an electrode array, via the tongue, to the person's brain. The human brain is able to interpret these impulses as visual signals and they are then redirected to the visual cortex, allowing the person to "see." This is similar in part to how a cochlear implant works, in that it transmits electrical stimuli to a receiving device in the body. The BrainPort V100 oral electronic vision aid was approved by the Food and Drug Administration (FDA) on 18 June 2015.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1338802343 under CC BY-SA 4.0; modifications have been made.